Gilead Sciences (GILD)
NASDAQ:GILD

Gilead Sciences (GILD) Stock Forecast & Price Target

11,693 Followers
See the Price Targets and Ratings of:

GILD Analyst Ratings

Moderate Buy
18Ratings
10 Buy
8 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Gilead
Sciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GILD Stock 12 Months Forecast

Average Price Target

$84.29
▼(-5.32% Downside)
Based on 18 Wall Street analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $84.29 with a high forecast of $105.00 and a low forecast of $63.00. The average price target represents a -5.32% change from the last price of $89.03.
Highest Price Target$105.00Average Price Target$84.29Lowest Price Target$63.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Piper Sandler
$96.00
Buy
7.83%
Upside
Upgraded
Gilead upgraded to Overweight from Neutral at Piper SandlerGilead upgraded to Overweight from Neutral at Piper Sandler
BMO Capital
$63.00
Hold
-29.24%
Downside
Assigned
Gilead price target raised to $72 from $63 at BMO CapitalGilead price target raised to $72 from $63 at BMO Capital
Wells Fargo
$75.00
Hold
-15.76%
Downside
Reiterated
Wells Fargo Keeps Their Hold Rating on Gilead Sciences (GILD)
Needham
Hold
Reiterated
Needham Reaffirms Their Hold Rating on Gilead Sciences (GILD)
J.P. Morgan
$87.00
Buy
-2.28%
Downside
Reiterated
Gilead Sciences (GILD) PT Raised to $87 at JPMorganJPMorgan analyst Chris Schott raised the price target on Gilead Sciences (NASDAQ: GILD) to $87.00 (from $80.00) while maintaining a Overweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

GILD Financial Forecast

GILD Earnings Forecast
Next quarter’s earnings estimate for GILD is $1.50 with a range of $1.30 to $1.71. The previous quarter’s EPS was $1.90. GILD beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.41% of the time in the same period. In the last calendar year GILD has Outperformed its overall industry.
Next quarter’s earnings estimate for GILD is $1.50 with a range of $1.30 to $1.71. The previous quarter’s EPS was $1.90. GILD beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.41% of the time in the same period. In the last calendar year GILD has Outperformed its overall industry.
GILD Sales Forecast
Next quarter’s sales forecast for GILD is $6.64B with a range of $6.36B to $7.25B. The previous quarter’s sales results were $6.99B. GILD beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 42.90% of the time in the same period. In the last calendar year GILD has Outperformed its overall industry.
Next quarter’s sales forecast for GILD is $6.64B with a range of $6.36B to $7.25B. The previous quarter’s sales results were $6.99B. GILD beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 42.90% of the time in the same period. In the last calendar year GILD has Outperformed its overall industry.
GILD Analyst Recommendation Trends
In the current month, GILD has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The GILD average analyst price target in the past 3 months is $84.29
In the current month, GILD has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The GILD average analyst price target in the past 3 months is $84.29

GILD Stock Forecast FAQ

What is GILD’s average 12-month price target, according to analysts?
Based on analyst ratings, Gilead Sciences’s 12-month average price target is $84.29.
    What is GILD’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for GILD, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is GILD a Buy, Sell or Hold?
        Gilead Sciences has a conensus rating of Moderate Buy which is based on 10 buy ratings, 8 hold ratings and 0 sell ratings.
          What is Gilead Sciences’s price target?
          The average price target for Gilead Sciences is $84.29. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $105.00 ,the lowest forecast is $63.00. The average price target represents -5.32% Decrease from the current price of $89.03.
            What do analysts say about Gilead Sciences?
            Gilead Sciences’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis